Holders — by stockHoldings — by fund
a16z Capital Management, L.L.C.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001540358
$14.21B
disclosed book value
19
positions
90%
largest position share
Positions, as of 2026-06-30
top 19 of 19 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | SPCXSPACE EXPLORATION TECHN CORP | 74.9M | $12.79B | 90% |
| 2 | NAVNNAVAN INC | 28.2M | $645.4M | 4.5% |
| 3 | RVMDREVOLUTION MEDICINES INC | 921,099 | $172.5M | 1.2% |
| 4 | METAMETA PLATFORMS INC | 212,531 | $119.7M | 0.8% |
| 5 | FIGFIGMA INC | 6.0M | $108.2M | 0.8% |
| 6 | BIOABIOAGE LABS INC | 3.2M | $79.2M | 0.6% |
| 7 | XYZBLOCK INC | 1.0M | $77.3M | 0.5% |
| 8 | ERASERASCA INC | 2.9M | $52.4M | 0.4% |
| 9 | MAZEMAZE THERAPEUTICS INC | 1.7M | $50.8M | 0.4% |
| 10 | DAMORA THERAPEUTICS INC | 1.2M | $32.2M | 0.2% |
| 11 | OMDAOMADA HEALTH INC | 1.2M | $25.3M | 0.2% |
| 12 | NAUTNAUTILUS BIOTECHNOLOGY INC | 9.1M | $16.9M | 0.1% |
| 13 | RBLXROBLOX CORP | 274,570 | $14.9M | 0.1% |
| 14 | AKTSAKTIS ONCOLOGY INC | 415,000 | $13.4M | 0.1% |
| 15 | CAMPCAMP4 THERAPEUTICS CORP | 2.1M | $9.3M | 0.1% |
| 16 | BTGOBITGO HOLDINGS INC | 666,356 | $3.5M | 0% |
| 17 | KLRAKAILERA THERAPEUTICS INC | 140,000 | $3.1M | 0% |
| 18 | DNAGINKGO BIOWORKS HOLDINGS INC | 108,568 | $1.1M | 0% |
| 19 | IPSTIP STRATEGY HOLDINGS INC | 4,137 | $9,722 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.